Reversible Tumorigenesis by MYC in Hematopoietic Lineages

This publication has 35 references indexed in Scilit:

• Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
  Oncogene, 1998
• BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
  The Lancet, 1997
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
  Proceedings of the National Academy of Sciences, 1996
• Apoptosis and the cell cycle
  Current Opinion in Cell Biology, 1995
• myc FUNCTION AND REGULATION
  Annual Review of Biochemistry, 1992
• Cooperation between oncogenes
  Cell, 1991
• Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
  Science, 1990
• Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
  The Journal of Experimental Medicine, 1989
• Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development
  Cell, 1986
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  Nature, 1985